Port site metastasis after robotic assisted laparoscopic radical prostatectomy: Diagnosis via prostate-specific membrane antigen (PSMA)-targeted
Publication/Presentation Date
7-1-2025
Abstract
We present a case of port site metastasis (PSM) that was identified in an 82-year-old man with an elevated prostate-specific antigen (PSA) to 3.9 ng/mL, concerning for biochemical recurrence after robotic-assisted radical prostatectomy, adjuvant radiation, and six months of androgen deprivation therapy with an undetectable PSA post-treatment over 10 years ago. A 2.1 cm solitary tracer avid nodule on the right lateral abdominal wall with no other evidence of recurrence or metastatic disease was found on prostate-specific membrane antigen (PSMA)-targeted
Volume
61
First Page
103082
Last Page
103082
ISSN
2214-4420
Published In/Presented At
Leong, J. Y., D'Amico, M. J., Capella, C. E., Gomella, L. G., & Izes, J. K. (2025). Port site metastasis after robotic assisted laparoscopic radical prostatectomy: Diagnosis via prostate-specific membrane antigen (PSMA)-targeted 18F-DCFPyL PET/CT. Urology case reports, 61, 103082. https://doi.org/10.1016/j.eucr.2025.103082
Disciplines
Business Administration, Management, and Operations | Health and Medical Administration | Management Sciences and Quantitative Methods
PubMedID
40510628
Department(s)
Administration and Leadership
Document Type
Article